1. Home
  2. SMSI vs QNCX Comparison

SMSI vs QNCX Comparison

Compare SMSI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Micro Software Inc.

SMSI

Smith Micro Software Inc.

HOLD

Current Price

$0.87

Market Cap

18.2M

Sector

Technology

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$1.23

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMSI
QNCX
Founded
1982
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
19.9M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
SMSI
QNCX
Price
$0.87
$1.23
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
102.2K
1.5M
Earning Date
04-29-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
62.94
N/A
EPS
N/A
N/A
Revenue
$17,363,000.00
N/A
Revenue This Year
$13.97
N/A
Revenue Next Year
$53.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.08
52 Week High
$1.30
$4.55

Technical Indicators

Market Signals
Indicator
SMSI
QNCX
Relative Strength Index (RSI) 63.99 61.69
Support Level $0.67 $1.17
Resistance Level N/A $1.50
Average True Range (ATR) 0.05 0.10
MACD 0.00 -0.04
Stochastic Oscillator 77.81 19.44

Price Performance

Historical Comparison
SMSI
QNCX

About SMSI Smith Micro Software Inc.

Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: